200 related articles for article (PubMed ID: 28955051)
1. Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function.
van Horck M; Winkens B; Wesseling G; van Vliet D; van de Kant K; Vaassen S; de Winter-de Groot K; de Vreede I; Jöbsis Q; Dompeling E
Sci Rep; 2017 Sep; 7(1):12350. PubMed ID: 28955051
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.
Hoppe JE; Wagner BD; Sagel SD; Accurso FJ; Zemanick ET
BMC Pulm Med; 2017 Dec; 17(1):188. PubMed ID: 29228933
[TBL] [Abstract][Full Text] [Related]
4. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations.
West NE; Beckett VV; Jain R; Sanders DB; Nick JA; Heltshe SL; Dasenbrook EC; VanDevanter DR; Solomon GM; Goss CH; Flume PA;
J Cyst Fibros; 2017 Sep; 16(5):600-606. PubMed ID: 28457954
[TBL] [Abstract][Full Text] [Related]
5. Electronic home monitoring of children with cystic fibrosis to detect and treat acute pulmonary exacerbations and its effect on 1-year FEV
Yanaz M; Yilmaz Yegit C; Gulieva A; Kalyoncu M; Selcuk M; Uzunoglu B; Tastan G; Ergenekon AP; Gokdemir Y; Erdem Eralp E; Karakoc F; Karadag B
J Cyst Fibros; 2024 Mar; 23(2):329-333. PubMed ID: 37748990
[TBL] [Abstract][Full Text] [Related]
6. Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
Heltshe SL; Goss CH; Thompson V; Sagel SD; Sanders DB; Marshall BC; Flume PA
Thorax; 2016 Mar; 71(3):223-9. PubMed ID: 25911223
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for lung disease progression in children with cystic fibrosis.
van Horck M; van de Kant K; Winkens B; Wesseling G; Gulmans V; Hendriks H; van der Grinten C; Jöbsis Q; Dompeling E
Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29773689
[TBL] [Abstract][Full Text] [Related]
8. A prospective pilot study of home monitoring in adults with cystic fibrosis (HOME-CF): protocol for a randomised controlled trial.
Choyce J; Shaw KL; Sitch AJ; Mistry H; Whitehouse JL; Nash EF
BMC Pulm Med; 2017 Jan; 17(1):22. PubMed ID: 28114922
[TBL] [Abstract][Full Text] [Related]
9. Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results.
Lechtzin N; Mayer-Hamblett N; West NE; Allgood S; Wilhelm E; Khan U; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Gibson RL; Orenstein D; Milla C; Clancy JP; Antony V; Goss CH;
Am J Respir Crit Care Med; 2017 Nov; 196(9):1144-1151. PubMed ID: 28608719
[TBL] [Abstract][Full Text] [Related]
10. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.
Sanders DB; Solomon GM; Beckett VV; West NE; Daines CL; Heltshe SL; VanDevanter DR; Spahr JE; Gibson RL; Nick JA; Marshall BC; Flume PA; Goss CH;
J Cyst Fibros; 2017 Sep; 16(5):592-599. PubMed ID: 28460885
[TBL] [Abstract][Full Text] [Related]
11. Home-spirometry exacerbation profiles in children with cystic fibrosis.
Bouteleux B; Beaufils F; Fayon M; Bui S
Pediatr Pulmonol; 2024 Mar; 59(3):552-561. PubMed ID: 38014613
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site.
Schechter MS; Regelmann WE; Sawicki GS; Rasouliyan L; VanDevanter DR; Rosenfeld M; Pasta D; Morgan W; Konstan MW
Pediatr Pulmonol; 2015 May; 50(5):431-40. PubMed ID: 25530325
[TBL] [Abstract][Full Text] [Related]
13. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
[TBL] [Abstract][Full Text] [Related]
14. Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis.
Wagener JS; VanDevanter DR; Konstan MW; Pasta DJ; Millar SJ; Morgan WJ
Pediatr Pulmonol; 2020 Mar; 55(3):828-834. PubMed ID: 31746561
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis.
Sequeiros IM; Jarad N
Chron Respir Dis; 2012 Feb; 9(1):9-16. PubMed ID: 22308550
[TBL] [Abstract][Full Text] [Related]
16. Variability of lung clearance index in clinically stable cystic fibrosis lung disease in school age children.
Svedberg M; Gustafsson PM; Robinson PD; Rosberg M; Lindblad A
J Cyst Fibros; 2018 Mar; 17(2):236-241. PubMed ID: 28822728
[TBL] [Abstract][Full Text] [Related]
17. Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis.
VanDevanter DR; Heltshe SL; Spahr J; Beckett VV; Daines CL; Dasenbrook EC; Gibson RL; Raksha J; Sanders DB; Goss CH; Flume PA;
J Cyst Fibros; 2017 Sep; 16(5):607-615. PubMed ID: 28438499
[TBL] [Abstract][Full Text] [Related]
18. Improved recognition of lung function decline as signal of cystic fibrosis pulmonary exacerbation: a Cystic Fibrosis Learning Network Innovation Laboratory quality improvement initiative.
List R; Solomon G; Bichl S; Horton BJ; Shen S; Corcoran B; Sadeghi H; Britto MT; Ren C; Albon D;
BMJ Open Qual; 2023 Dec; 12(4):. PubMed ID: 38154821
[TBL] [Abstract][Full Text] [Related]
19. BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis.
Schultz A; McLeod C; Berry S; Marsh J; McKenzie A; Messer M; Wood J; Saville B; Jaffe A; Ranganathan S; Stick S; Wark P; Webb S; Snelling T
Trials; 2023 Mar; 24(1):211. PubMed ID: 36949472
[TBL] [Abstract][Full Text] [Related]
20. Quantitative chest computerized tomography and FEV
Sanders DB; Li Z; Parker-McGill K; Farrell P; Brody AS
Pediatr Pulmonol; 2018 Oct; 53(10):1369-1377. PubMed ID: 30160050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
